Advertisement
Advertisement
OGN
Organon & Co.
8.21
USDSponsored
+0.12
+1.42%
Feb 06, 15:58 UTC -5
Closed
After-Market
8.22
+0.01
+0.06%
OGN Earnings Reports
Positive Surprise Ratio
OGN beat 15 of 19 last estimates.
79%
Next Report
Next Week
Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.55B
/$0.74
Implied change from Q3 25 (Revenue/ EPS)
-2.96%
/-26.73%
Implied change from Q4 24 (Revenue/ EPS)
-2.35%
/-17.78%
Organon & Co. earnings per share and revenue
On Nov 10, 2025, OGN reported earnings of 1.01 USD per share (EPS) for Q3 25, beating the estimate of 0.94 USD, resulting in a 6.80% surprise. Revenue reached 1.60 billion, compared to an expected 1.59 billion, with a 0.71% difference. The market reacted with a +13.72% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.74 USD, with revenue projected to reach 1.55 billion USD, implying an decrease of -26.73% EPS, and decrease of -2.96% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Cencora, Inc.
Report Date
Feb 04, 2026 For Q1 26
Estimate
$4.07
Actual
$4.08
Surprise
+0.16%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
InnovAge Holding Corp. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
$0.04
Actual
$0.08
Surprise
+96.08%
Embecta Corp. Common Stock
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.68
Actual
$0.71
Surprise
+3.89%
FAQ
What were Organon & Co.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Organon & Co. reported EPS of $1.01, beating estimates by 6.8%, and revenue of $1.60B, 0.71% above expectations.
How did the market react to Organon & Co.'s Q3 2025 earnings?
The stock price moved up 13.72%, changed from $6.78 before the earnings release to $7.71 the day after.
When is Organon & Co. expected to report next?
The next earning report is scheduled for Feb 12, 2026.
What are the forecasts for Organon & Co.'s next earnings report?
Based on 9
analysts, Organon & Co. is expected to report EPS of $0.74 and revenue of $1.55B for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement